U.S. Pharma Stock News

NYSE:WTS
NYSE:WTSMachinery

Watts Water Recognition Adds ESG Dimension To Share Performance And Valuation

Watts Water Technologies (NYSE:WTS) has been recognized on Newsweek’s 2026 Most Charitable Companies list. The award highlights the company’s philanthropic impact and ongoing community engagement efforts. For investors tracking Watts Water Technologies at a share price of $303.28, this new recognition adds another dimension to a story that has recently centered on financial results and valuation. The stock has returned 8.9% year to date and 48.0% over the past year, while the 3 year and 5...
NasdaqGS:LPLA
NasdaqGS:LPLACapital Markets

Advisor Moves Test LPL Financial Story On Growth And Retention

Furstenau Financial, a large wealth advisory team, has left LPL Financial Holdings for Carson Group, taking its client relationships to a rival platform. At the same time, LPL has added Legacy Ridge Private Wealth as a new independent practice through its Strategic Wealth model. These moves highlight both competitive pressures on LPL’s advisor network and the firm’s efforts to attract and support new practices. For investors watching LPL Financial Holdings (NasdaqGS:LPLA), these advisor...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

Assessing Exelixis (EXEL) Valuation After Analysts Lift 2026 Earnings Forecasts

Exelixis (EXEL) is back on investor radars after six analysts raised their earnings forecasts for fiscal 2026, citing the company’s oncology pipeline and their growth expectations as key reasons for the revised outlook. See our latest analysis for Exelixis. Even with the recent analyst optimism, Exelixis’ shares have cooled slightly, with a 30 day share price return of a 4.21% decline and a year to date share price return of a 5.53% decline. At the same time, the 1 year total shareholder...
NYSE:LYB
NYSE:LYBChemicals

US Stock Market Today S&P 500 Futures Slip As Yields And Energy Costs Climb

The Morning Bull - US Market Morning Update Friday, Mar, 13 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 contracts down about 0.2%, as investors react to a fresh jump in government bond yields and renewed energy worries. The US 10 year yield is around 4.26%, which makes borrowing more expensive and can pressure valuations for growth focused companies. At the same time, commodity futures are higher and the US is weighing a temporary shipping rule waiver to ease an...
NasdaqCM:VRRM
NasdaqCM:VRRMProfessional Services

Assessing Verra Mobility (VRRM) Valuation After Prolonged Share Price Weakness

Why Verra Mobility Is On Investors’ Radar Today Verra Mobility (VRRM) has seen pressure on its share price in recent months, with negative returns over the past month, past 3 months, year to date, and the past year putting recent performance in focus for investors. See our latest analysis for Verra Mobility. With the share price at US$15.16 and a 30 day share price return of an 18.8% decline, Verra Mobility’s momentum has been fading, and its 1 year total shareholder return of a 24.95%...
NYSE:ALG
NYSE:ALGMachinery

Soft Q4 Results And Restructuring Year Might Change The Case For Investing In Alamo Group (ALG)

In March 2026, Alamo Group Inc. reported fourth-quarter 2025 sales of US$373.65 million and net income of US$15.51 million, both down from the prior year, with full-year earnings per share from continuing operations also lower than in 2024. Management described 2025 as a transitional year involving restructuring and sharper priorities, while the company missed analyst expectations and posted the weakest performance versus estimates in its agricultural machinery peer group. Against this...
NasdaqGS:MAT
NasdaqGS:MATLeisure

Is It Time To Reconsider Mattel (MAT) After The Recent Share Price Slide

If you are wondering whether Mattel's current share price reflects its true worth, this article will walk through what the numbers are saying about the stock's value. Mattel recently closed at US$16.22, with returns of 1.2% over 7 days, a 23.0% decline over 30 days, and year to date and 1 year returns of 19.1% and 17.5% declines respectively. These moves may have shifted how the market views both its potential and its risks. Recent coverage around Mattel has focused on its position in the...
NYSE:HL
NYSE:HLMetals and Mining

Is It Too Late To Consider Hecla Mining (HL) After Its 256% One Year Surge

If you are wondering whether Hecla Mining's share price still reflects its underlying value after a strong run, this article walks through what the numbers are actually saying about the stock. The shares last closed at US$20.53, with returns of a 1.3% decline over the past week, a 10.7% decline over the past month, gains of 8.8% year to date, 256.4% over the last year, 286.1% over three years, and 216.6% over five years. Recent headlines around Hecla Mining have focused on the company as a...
NYSE:MSGS
NYSE:MSGSEntertainment

A Look At Madison Square Garden Sports (MSGS) Valuation After Increased Stakes From Gabelli And GAMCO

Recent filings show Mario Gabelli and GAMCO Investors increasing their positions in Madison Square Garden Sports (MSGS), highlighting the New York Knicks and Rangers as core assets that some investors view as potentially undervalued opportunities. See our latest analysis for Madison Square Garden Sports. At a share price of $312.31, Madison Square Garden Sports has given investors a 31.53% 3 month share price return and a 68.13% 1 year total shareholder return, suggesting momentum has been...
NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

Assessing Cognex (CGNX) Valuation After Strong 1 Year Returns And A High P/E Multiple

Why Cognex may be on your radar now Cognex (CGNX) has drawn attention after a mixed stretch in the share price, with a small pullback over the past week following gains over the past month and the past 3 months. See our latest analysis for Cognex. At a share price of US$48.77, Cognex has given investors a 36.8% 90 day share price return and a 62.47% 1 year total shareholder return, which signals building momentum despite the recent 1 day and 7 day pullback. If Cognex's recent move has you...
NasdaqGM:CRVS
NasdaqGM:CRVSBiotechs

Corvus Trials Progress And Cash Raise Reframe Soquelitinib Risk Reward Profile

Corvus Pharmaceuticals has moved its lead candidate, soquelitinib, into late-stage Phase 3 and Phase 2 trials across several indications. The company raised $189 million in a follow-on offering, which it says extends its cash runway into 2028. Corvus Pharmaceuticals (NasdaqGM:CRVS) is drawing attention after pushing soquelitinib into more advanced clinical trials while securing fresh capital to support the work. The stock trades at $16.01, with very large 3-year and 1-year returns, and a...
NasdaqGS:FRME
NasdaqGS:FRMEBanks

Assessing First Merchants (FRME) Valuation After Recent Share Price Weakness

If you are wondering whether First Merchants at around US$36.55 is offering good value today, you are not alone. This article will walk through what the current price may be implying. The stock has seen mixed returns, with a 5.2% decline over the last 7 days and a 12.5% decline over the last 30 days, while the 3 year return sits at 11.9% and the 1 year return at a 2.9% decline. Recent trading moves have put more attention on how investors are pricing regional banks like First Merchants and...
NYSE:NUE
NYSE:NUEMetals and Mining

Nucor Commercial Chief Retirement Puts Succession And Pricing Discipline In Focus

Nucor Corporation (NYSE:NUE) announced that Executive Vice President of Commercial, Daniel R. Needham, plans to retire after a long tenure with the company. His retirement marks the departure of a senior leader who has held a key commercial role within Nucor. The company has described this as a planned transition, giving stakeholders time to assess potential implications for commercial operations and leadership continuity. Nucor, a major US steel producer, operates at the center of sectors...
NYSE:ATEN
NYSE:ATENSoftware

A Look At A10 Networks (ATEN) Valuation After Fresh Optimism On AI Security Demand

A10 Networks (ATEN) is back in focus after a research firm highlighted what it sees as strong demand for the company’s network security products tied to AI infrastructure, surging traffic, and expanding customer data centers. See our latest analysis for A10 Networks. The latest AI related enthusiasm comes after a period of steady gains, with the share price at US$21.06 and a 90 day share price return of 16.23%, while the 5 year total shareholder return of 125.84% points to sustained investor...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

Is Precigen (PGEN) Reflecting Its Recent Surge Despite Steep Short Term Pullback

If you are trying to figure out whether Precigen's current share price reflects its underlying value, you are not alone. This article is built to walk you through that question step by step. The stock last closed at US$3.28, with returns of 88.5% over 1 year and 203.7% over 3 years, but also a 29.6% decline over 30 days and a 23.4% decline year to date. These moves can change how investors think about both potential and risk. Recent company updates and sector news have kept Precigen on many...
NYSE:FUN
NYSE:FUNHospitality

Is It Time To Reassess Six Flags Entertainment (FUN) After Its Prolonged Share Price Slump?

If you are wondering whether Six Flags Entertainment is a bargain or a value trap at around US$15.57 per share, this article walks through what the numbers actually say about the stock's current price. The share price is roughly flat year to date with a 0.5% return, but the stock has seen a 11.1% decline over the last 7 days, a 13.8% decline over the last 30 days, and a 55.6% decline over the past year, along with a 64.0% and 67.0% decline over the last 3 and 5 years respectively, which is...
NasdaqGS:SIRI
NasdaqGS:SIRIMedia

A Look At Sirius XM (SIRI) Valuation After Recent Debt Refinancing And Lower Near Term Obligations

Debt refinancing puts Sirius XM Holdings (SIRI) capital structure in focus Sirius XM Holdings (SIRI) recently refinanced part of its balance sheet by issuing new 2032 notes and using the proceeds to retire about US$498.9 million of 3.125% Senior Notes due 2026. The company also satisfied and discharged the remaining 2026 note obligations by depositing US treasuries with the trustee, reducing near-term debt commitments and giving investors fresh information to assess its capital...
NYSE:HG
NYSE:HGInsurance

Do Hamilton’s New Underwriting Leaders Reshape HG’s Strategic Edge In Specialty Reinsurance?

Hamilton Insurance Group recently reshaped leadership at its London-based Hamilton Global Specialty unit, appointing long-time executive Sinead Cormican as Chief Underwriting Officer while she continues as Active Underwriter of Syndicate 4000, and expanding Richard Northcott’s responsibilities to include Head of Business Development Strategy alongside Marine and Energy. These changes follow a quarter in which Hamilton reported a 27.7% year-on-year revenue increase and the largest analyst...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

Why uniQure (QURE) Is Up 59.1% After FDA Oversight Shift and AMT-130 Analyst Upgrades – And What's Next

In early March 2026, uniQure reported full-year 2025 results showing revenue of US$16.1 million and a net loss of US$198.97 million, while also facing multiple securities class action lawsuits over alleged misstatements about FDA interactions for its AMT-130 Huntington’s disease gene therapy. At the same time, sentiment around uniQure has shifted as several banks upgraded the stock after news that the FDA official overseeing AMT-130 will step down, raising questions about how a possible...
NasdaqGS:ENVX
NasdaqGS:ENVXElectrical

Is Enovix (ENVX) Starting To Look Interesting After Recent Share Price Slide?

If you are wondering whether Enovix at around US$4.92 is starting to look interesting or still too risky for your portfolio, this article will help you size up what you are really paying for. The share price has been under pressure, with returns of a 2.6% decline over 7 days, 21.7% decline over 30 days, 37.6% decline year to date, 31.8% decline over 1 year, 54.7% decline over 3 years and 67.4% decline over 5 years. Recent coverage has focused on Enovix's position in advanced battery...
NasdaqGS:CCB
NasdaqGS:CCBBanks

Does Board Expansion and Fintech Hire Reshape the Bull Case for Coastal Financial’s BaaS Strategy (CCB)?

Coastal Financial Corporation recently expanded its Board of Directors to twelve members by appointing fintech veteran Jeffrey M. Chapman, who will serve on the Technology Committee and the CCBX Oversight Committee, reinforcing its focus on technology governance and digital banking innovation. This board appointment comes alongside reports of very large multi‑year net interest income growth, a strong 7.1% net interest margin, and outperformance in earnings per share growth versus peers,...
NYSE:PCOR
NYSE:PCORSoftware

A Look At Procore Technologies (PCOR) Valuation After New CFO And CRO Appointments

Procore Technologies (PCOR) has put fresh leadership at the center of its story, with Rachel Pyles stepping in as CFO and Walt Hearn as CRO on April 1, 2026, while outgoing leaders shift into advisory roles. See our latest analysis for Procore Technologies. Those leadership appointments come as Procore’s share price, now at US$57.03, reflects mixed momentum, with a 30 day share price return of 8.73% set against a 90 day share price return decline of 23.40% and a 1 year total shareholder...
NasdaqGM:SIGA
NasdaqGM:SIGAPharmaceuticals

A Look At SIGA Technologies (SIGA) Valuation After 2025 Earnings, New TPOXX Orders And Funding

SIGA Technologies (SIGA) is back in focus after its 2025 earnings showed lower year over year revenue and net income, alongside fresh government funding, new international TPOXX orders, and pending European regulatory decisions. See our latest analysis for SIGA Technologies. The share price has come under pressure around the earnings release, with a 7 day share price return of 12.34% and a 30 day share price return of an 18.24% decline, even though the 1 year total shareholder return is...
NYSE:TAP
NYSE:TAPBeverage

Molson Coors Taps Simply Spiked Bolder To Support Growth Story

Molson Coors Beverage (NYSE:TAP) has introduced Simply Spiked Bolder, a new 12% ABV flavored alcoholic drink under its partnership with Coca-Cola. The product expands the existing Simply Spiked line with a higher-strength, portable option aimed at the high-ABV flavored alcoholic drinks segment. The launch comes as the company addresses volume and profit pressures and looks to refine its product mix. For you as an investor, Simply Spiked Bolder sits at the intersection of two important...